Haleon plc Form 6-K Summary
Business context and reporting period
Haleon plc filed a Form 6-K for October 2022 on October 10, 2022. The filing comprises two UK Market Abuse Regulation notifications concerning conditional share-based awards granted to directors and other persons discharging managerial responsibilities on October 6, 2022. It does not report quarterly or annual operating results.
Financial and operating metrics
- Revenue, profit, cash flow and margins: No operating or financial results are provided in the filing.
- Debt and liquidity: No current debt or liquidity amounts are provided. The filing references a 2024 performance target of net debt to adjusted EBITDA of 3.0x at threshold and 2.4x at maximum vesting.
- Share awards: Executive Directors received 2,049,305 shares for CEO Brian McNamara and 892,587 shares for CFO Tobias Hestler under the 2022 Performance Share Plan.
Material changes versus the prior comparable period
The filing text does not provide a prior-period comparison. It documents the initial grant of 2022 incentive awards and related awards to multiple PDMRs, generally at nil price. Awards included Performance Share Plan grants, Share Value Plan and refill awards, and, for one executive, a cash-based Deferred Investment Award linked to Haleon ordinary share price.
Guidance, outlook, commentary, risks and unusual items
- The 2022–2024 Performance Share Plan awards will vest after announcement of FY 2024 results, subject to performance and a two-year post-vesting holding period.
- Performance Share Plan measures are weighted 50% to cumulative free cash flow and 50% to year-end 2024 net debt to adjusted EBITDA.
- Free cash flow targets are £4.557 billion at threshold, representing 25% vesting, and £5.557 billion at maximum, representing 100% vesting, measured cumulatively over FY 2022–FY 2024.
- An ESG qualifier may reduce vesting if milestones relating to carbon reduction, recycle-ready packaging and diversity are not achieved.
- For the 2022 Annual Incentive Plan, performance measures are organic sales growth at 60%, adjusted operating profit at 20% and individual business objectives at 20%. Executives must defer 50% of any earned award into shares that normally vest on the third anniversary of grant.
- Full performance targets were scheduled for disclosure in the 2022 Directors’ Remuneration Report, expected in the first half of 2023; actual performance and vesting outcomes were not provided here.
Important facts for investors to verify
- Verify the eventual FY 2022–FY 2024 cumulative free cash flow and 2024 net debt-to-adjusted-EBITDA outcomes against the stated vesting ranges.
- Verify whether the ESG qualifier reduced vesting and review the related disclosures in the 2024 Directors’ Remuneration Report.
- Assess potential dilution from the conditional ordinary share and American Depositary Share awards, including awards to non-executive PDMRs.
- Confirm the 2022 Annual Incentive Plan outcomes and the amount deferred into shares.
- Do not interpret this filing as evidence of current revenue, profitability, cash flow or liquidity performance; those figures are not included.